Pay in 4 interest-free payments of $6.32 Learn more
Ships within 48 hours · Estimated delivery Aug 28 - Sep 2
At Everest Regenerative Medicine, healing begins with collaboration and continues through care
The current FDA status of BPC-157 is that of an unapproved drug compound with no active Investigational New Drug (IND) application accepted for human clinical trials as of available records
It's one of the most researched healing peptides, with hundreds of animal studies on tissue repair, gut healing, tendon recovery, and neuroprotection
Because of its potent anabolic effects, it is often reserved for specialized recovery or performance protocols
Researchers noted evidence of cartilage repair and potential reduction in surgical need, representing one of the most cited human clinical data points for intra-articular BPC-157 use
US$ 24.97
US$ 24.29
US$ 28.34
